185 related articles for article (PubMed ID: 3284698)
1. Recent advances in laboratory tests for autoantibodies to thyrotropin receptor protein in Graves' disease.
Gupta MK
Clin Lab Med; 1988 Jun; 8(2):303-23. PubMed ID: 3284698
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
Ginsberg J; von Westarp C
CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
[TBL] [Abstract][Full Text] [Related]
3. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
4. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin receptor autoantibodies in Graves' disease.
Schott M; Scherbaum WA; Morgenthaler NG
Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
[TBL] [Abstract][Full Text] [Related]
6. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
7. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
Minich WB; Weymayer JD; Loos U
Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
[TBL] [Abstract][Full Text] [Related]
8. Measurement of stimulating TSH receptor antibodies in sera of patients with Graves' disease by a recombinant TSH receptor bioassay.
Derwahl M; Schatz H; Bolle B; Pohl A; Meyer K
Exp Clin Endocrinol; 1992; 100(1-2):75-9. PubMed ID: 1361452
[No Abstract] [Full Text] [Related]
9. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
10. Techniques to quantify TSH receptor antibodies.
Ajjan RA; Weetman AP
Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):461-8. PubMed ID: 18574503
[TBL] [Abstract][Full Text] [Related]
11. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
12. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
[TBL] [Abstract][Full Text] [Related]
13. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
Schott M; Feldkamp J; Bathan C; Fritzen R; Scherbaum WA; Seissler J
Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
[TBL] [Abstract][Full Text] [Related]
14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
15. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
16. [Current topics on immunological laboratory tests-thyroid diseases].
Iwatani Y
Rinsho Byori; 2004 Sep; 52(9):751-8. PubMed ID: 15552935
[TBL] [Abstract][Full Text] [Related]
17. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.
Costagliola S; Morgenthaler NG; Hoermann R; Badenhoop K; Struck J; Freitag D; Poertl S; Weglöhner W; Hollidt JM; Quadbeck B; Dumont JE; Schumm-Draeger PM; Bergmann A; Mann K; Vassart G; Usadel KH
J Clin Endocrinol Metab; 1999 Jan; 84(1):90-7. PubMed ID: 9920067
[TBL] [Abstract][Full Text] [Related]
18. [Significance of TSH receptor antibody determination].
Gannage MH; Haddad F; Jambart S; Atallah C; Halaby G
J Med Liban; 1996; 44(3):134-7. PubMed ID: 9296963
[TBL] [Abstract][Full Text] [Related]
19. [Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].
Paunković N; Paunković D
Med Pregl; 1995; 48(1-2):10-4. PubMed ID: 8657049
[TBL] [Abstract][Full Text] [Related]
20. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.
Balázs C; Molnár I
Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]